文献速递放疗物理与技术姑息放疗与转移瘤

空间分割放疗的当前综述:回到未来?

A Current Review of Spatial Fractionation: Back to the Future?
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2019-01-23

空间分割放疗源于20世纪初,通过铅块或多叶准直器在靶区形成非均匀、筛状剂量分布,以谷峰剂量比参数化,机制涉及旁效应、微血管改变和免疫调节。适应证包括常规放疗不可治或放化疗难治的大块或局部晚期病变,早期临床试验显示部分缓解率超过90%且毒性轻微。三维格式、微束和质子阵列等技术发展迅速,但仍需更多临床和生物学数据以确定理想剂量学参数并制定稳健的临床适应证和指南。

要点

  • 空间分割放疗使用铅块或多叶准直器在靶区形成非均匀筛状剂量分布,谷峰剂量比是其剂量学参数。
  • 早期临床试验显示部分缓解率超过90%且毒性轻微。
  • 仍需更多临床和生物学数据以明确理想剂量学参数和制定稳健的临床适应证与指南。

核心结论

  • 空间分割放疗的早期临床试验显示部分缓解率超过90%且毒性轻微,但仍需更多临床和生物学数据以明确理想剂量学参数并制定稳健的临床适应证和指南。

研究设计与样本

  • 综述,回顾空间分割放疗的起源、实现方式、剂量学参数、放射生物学机制、当前适应证及技术发展。

主要发现

  • 空间分割放疗使用商用铅块或多叶准直器向靶区递送非共面、筛状模式的非均匀剂量分布。
  • 剂量学以冷点谷剂量与热点峰剂量的比值即谷峰剂量比参数化。
  • 放射生物学机制被推测涉及辐射诱导的旁效应、微血管改变和/或免疫调节。
  • 当前适应证包括常规放疗不可治或放化疗难治的大块或局部晚期病变。
  • 早期临床试验显示部分缓解率超过90%且毒性轻微。

局限性

  • 仍需更多临床和生物学数据以明确理想剂量学参数并制定稳健的临床适应证和指南以实现最佳标准化诊疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Spatially fractionated radiation therapy represents a significant departure from canonical thinking in radiation oncology despite having origins in the early 1900s. The original and most common implementation of spatially fractionated radiation therapy uses commercially available blocks or multileaf collimators to deliver a nonconfluent, sieve-like pattern of radiation to the target volume in a nonuniform dose distribution. Dosimetrically, this is parameterized by the ratio of the valley dose in cold spots to the peak dose in hot spots, or the valley-to-peak dose ratio. The radiobiologic mechanisms are postulated to involve radiation-induced bystander effects, microvascular alterations, and/or immunomodulation. Current indications include bulky or locally advanced disease that would not be amenable to conventional radiation or that has proved refractory to chemoradiation. Early-phase clinical trials have shown remarkable success, with some response rates >90% and minimal toxicity. This has promoted technological developments in 3-dimensional formats (LATTICE), micron-size beams (microbeam), and proton arrays. Nevertheless, more clinical and biological data are needed to specify ideal dosimetry parameters and to formulate robust clinical indications and guidelines for optimal standardized care.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Billena C, Khan AJ. A Current Review of Spatial Fractionation: Back to the Future? Int J Radiat Oncol Biol Phys. 2019. PMID: 30684666. doi:10.1016/j.ijrobp.2019.01.073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。